Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
about
Second malignant neoplasms and cardiovascular disease following radiotherapy.Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.Isolated clonal cytogenetic abnormalities after high-dose therapy.A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemiaInterstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study.Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical α-anomer.Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma.
P2860
Q26864522-6E9F67FA-ADF2-4304-A030-A0718CD9765DQ33435191-F1200266-78A4-452B-9C7E-B81B432B845FQ34108964-FFADE973-F212-4510-84D3-82D4837CEA45Q34204750-73A901C8-6EF1-4227-9839-ADD3FA22D255Q35136616-C952E842-3D1D-4A69-A723-0F5F669F25B0Q35819325-1823323D-0FCB-441E-BF3E-0C51FF94598EQ36672691-8BA49F18-1C63-495E-B7F9-9D0251D10C80Q36967098-70BD37B4-F6A8-4C6C-A444-3D8CC7F22B30Q37548821-B9466CA3-3C5E-4542-BE5D-0563D59D90B2Q37942816-FCC9A250-C92E-4FFB-A610-6B8059141E43Q38045706-9B7F9D6F-4631-41CA-A3F0-BA2CAC0E360BQ39129413-77046193-0B64-49C9-975E-CC034A6727D5Q40328857-1C8D2550-0795-447A-8497-6FD8753476D0Q40465178-B0D74AB5-8CED-48D1-96A2-F7A68AE5C1B4Q46060624-BF9BA48D-304D-41C4-9021-1CD502869F7EQ47593550-F7B9BBD6-F299-4857-86A9-FBE73983236AQ47876213-94103082-B25A-4920-A117-9A0AEAF1997BQ48201625-BD2BB3A9-FB31-40DB-BA4E-19D4414FA582Q53114614-981F0B01-93CB-4E10-BD22-A2F205A69ACF
P2860
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Risk of therapy-related myelod ...... on for non-Hodgkin's lymphoma.
@en
type
label
Risk of therapy-related myelod ...... on for non-Hodgkin's lymphoma.
@en
prefLabel
Risk of therapy-related myelod ...... on for non-Hodgkin's lymphoma.
@en
P2093
P356
P1433
P1476
Risk of therapy-related myelod ...... on for non-Hodgkin's lymphoma.
@en
P2093
B Andersson
I F Khouri
J Gajewski
M Körbling
R E Champlin
P304
P356
10.1093/ANNONC/MDF109
P577
2002-03-01T00:00:00Z